melatonin has been researched along with Neonatal Sepsis in 5 studies
Neonatal Sepsis: Blood infection that occurs in an infant younger than 90 days old. Early-onset sepsis is seen in the first week of life and most often appears within 24 hours of birth. Late-onset occurs after 1 week and before 3 months of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the effect of melatonin as an adjuvant therapy in the treatment of neonatal sepsis." | 9.27 | Beneficial effect of melatonin in the treatment of neonatal sepsis. ( El-Gendy, FM; El-Hawy, MA; Hassan, MG, 2018) |
| "The electronic databases including PubMed, Embase, and Cochrane Central Register of Controlled Trials were systematically searched on July 2017 for clinical studies that reported the effects of melatonin as an adjuvant therapy in neonatal sepsis." | 8.98 | Use of melatonin as adjunctive therapy in neonatal sepsis: A systematic review and meta-analysis. ( Henderson, R; Kim, S; Lee, E, 2018) |
| "The objective of this study is to evaluate melatonin concentration in the serum as a marker for neonatal sepsis and compare it to standard markers." | 7.83 | Can melatonin be used as a marker for neonatal sepsis? ( Aly, H; El-Dib, M; El-Mashad, AR; Elbatch, M; Elmahdy, H, 2016) |
| "To study the effect of melatonin as an adjuvant therapy in the treatment of neonatal sepsis." | 5.27 | Beneficial effect of melatonin in the treatment of neonatal sepsis. ( El-Gendy, FM; El-Hawy, MA; Hassan, MG, 2018) |
| "The electronic databases including PubMed, Embase, and Cochrane Central Register of Controlled Trials were systematically searched on July 2017 for clinical studies that reported the effects of melatonin as an adjuvant therapy in neonatal sepsis." | 4.98 | Use of melatonin as adjunctive therapy in neonatal sepsis: A systematic review and meta-analysis. ( Henderson, R; Kim, S; Lee, E, 2018) |
| "The objective of this study is to evaluate melatonin concentration in the serum as a marker for neonatal sepsis and compare it to standard markers." | 3.83 | Can melatonin be used as a marker for neonatal sepsis? ( Aly, H; El-Dib, M; El-Mashad, AR; Elbatch, M; Elmahdy, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Gendy, FM | 1 |
| El-Hawy, MA | 1 |
| Hassan, MG | 1 |
| D'Angelo, G | 1 |
| Marseglia, L | 1 |
| Reiter, RJ | 1 |
| Buonocore, G | 1 |
| Gitto, E | 1 |
| Zhang, Y | 1 |
| Liu, C | 1 |
| Wang, J | 1 |
| Li, X | 1 |
| Henderson, R | 1 |
| Kim, S | 1 |
| Lee, E | 1 |
| El-Mashad, AR | 1 |
| Elmahdy, H | 1 |
| El-Dib, M | 1 |
| Elbatch, M | 1 |
| Aly, H | 1 |
2 reviews available for melatonin and Neonatal Sepsis
| Article | Year |
|---|---|
Melatonin and Neonatal Sepsis: A Promising Antioxidant Adjuvant Agent.
Topics: Animals; Antioxidants; Disease Models, Animal; Humans; Melatonin; Neonatal Sepsis; Treatment Outcome | 2017 |
Use of melatonin as adjunctive therapy in neonatal sepsis: A systematic review and meta-analysis.
Topics: C-Reactive Protein; Complementary Therapies; Humans; Infant, Newborn; Melatonin; Neonatal Sepsis | 2018 |
1 trial available for melatonin and Neonatal Sepsis
| Article | Year |
|---|---|
Beneficial effect of melatonin in the treatment of neonatal sepsis.
Topics: Anti-Bacterial Agents; Case-Control Studies; Female; Gestational Age; Humans; Infant, Newborn; Inten | 2018 |
2 other studies available for melatonin and Neonatal Sepsis
| Article | Year |
|---|---|
Application of Monte Carlo cross-validation to identify pathway cross-talk in neonatal sepsis.
Topics: Dendritic Cells; Gene Expression Profiling; Gene Regulatory Networks; Glycolysis; Humans; Immune Sys | 2018 |
Can melatonin be used as a marker for neonatal sepsis?
Topics: Biomarkers; Case-Control Studies; Female; Humans; Infant, Newborn; Male; Melatonin; Neonatal Sepsis; | 2016 |